Özdemir et al., 2017 - Google Patents
Changes in serum albumin levels and neutrophil–lymphocyte ratio in patients with convulsive status epilepticusÖzdemir et al., 2017
- Document ID
- 1756645560243244118
- Author
- Özdemir H
- Akil E
- Acar A
- Tamam Y
- Varol S
- Cevik M
- Arikanoglu A
- Publication year
- Publication venue
- International Journal of Neuroscience
External Links
Snippet
Aim: Inflammation may be involved in the ictogenesis and development of some partial epilepsies. Serum albumin levels and the neutrophil–lymphocyte ratio (NLR) are markers of inflammation. The aim of this study was to investigate the ability of serum albumin levels and …
- 208000005809 Status Epilepticus 0 title abstract description 83
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/70—Mechanisms involved in disease identification
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/01—Social networking
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Özdemir et al. | Changes in serum albumin levels and neutrophil–lymphocyte ratio in patients with convulsive status epilepticus | |
Ekinci et al. | The connections among suicidal behavior, lipid profile and low-grade inflammation in patients with major depressive disorder: a specific relationship with the neutrophil-to-lymphocyte ratio | |
Adaway et al. | Serum and plasma 5-hydroxyindoleacetic acid as an alternative to 24-h urine 5-hydroxyindoleacetic acid measurement | |
Bakirci et al. | The role of the nonspecific inflammatory markers in determining the anatomic extent of venous thromboembolism | |
Yayan | Erythrocyte sedimentation rate as a marker for coronary heart disease | |
Kim et al. | Weight gain after smoking cessation does not modify its protective effect on myocardial infarction and stroke: evidence from a cohort study of men | |
Aitken et al. | Acute kidney injury: outcomes and quality of care | |
Ruiz-Alvarez et al. | Diagnostic efficacy and prognostic value of serum procalcitonin concentration in patients with suspected sepsis | |
Kinney et al. | Saliva/pathogen biomarker signatures and periodontal disease progression | |
Rana et al. | Clinical characterization and outcomes of preeclampsia with normal angiogenic profile | |
Vaara et al. | The attributable mortality of acute kidney injury: a sequentially matched analysis | |
Pelli et al. | Risk factors for recurrent acute alcohol-associated pancreatitis: a prospective analysis | |
Montgomery et al. | Metabolic biomarkers for predicting cardiovascular disease | |
Egberts et al. | Increased neutrophil–lymphocyte ratio in delirium: a pilot study | |
Wu | Prognosis in acute pancreatitis | |
Wan et al. | Combination of mean platelet volume and the GRACE risk score better predicts future cardiovascular events in patients with acute coronary syndrome | |
Acanfora et al. | Relative lymphocyte count as an indicator of 3-year mortality in elderly people with severe COPD | |
Heinisch et al. | Serial changes in plasma levels of cytokines in patients with coronary artery disease | |
Giynas Ayhan et al. | Neutrophil/lymphocyte and platelet/lymphocyte ratios in all mood states of bipolar disorder | |
Srinivasan et al. | Literature–Based Discovery of Salivary Biomarkers for Type 2 Diabetes Mellitus | |
Graupera et al. | Adipocyte fatty-acid binding protein is overexpressed in cirrhosis and correlates with clinical outcomes | |
Ha et al. | Fraction of immature granulocytes reflects severity but not mortality in sepsis | |
Jensvoll et al. | Existing data sources in clinical epidemiology: the Scandinavian Thrombosis and Cancer Cohort | |
Furer et al. | High red blood cell distribution width and preclinical carotid atherosclerosis | |
Zhang et al. | Systemic immune-inflammation index for predicting the prognosis of critically ill patients with acute pancreatitis |